It was found that ASF1B could well predict the prognosis of HCC patients at 1, 3 and 5 years, and its AUC under the ROC curve was 0.689, 0.621 and 0.617, respectively (Figure 2E). This evidence concerns the gene ASF1B and hepatocellular carcinoma.